Tech Company Financing Transactions
Corridor Pharmaceuticals Funding Round
Private investors invested in a $1.6 million funding round for Corridor Pharmaceuticals. The funding round was announced on 2/1/2013.
Transaction Overview
Company Name
Announced On
2/1/2013
Transaction Type
Debt
Amount
$1,558,429
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1122 Kenilworth Dr. 401
Towson, MD 21204
USA
Towson, MD 21204
USA
Phone
Website
Email Address
Overview
Corridor Pharmaceuticals is a platform-based pulmonary and critical care company developing novel therapeutics forelevated arginase levels.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Strobeck
Chief Scientific Officer
Peter Suzdak
VP - Finance
Anne Shiflett
Browse more venture capital transactions:
Prev: 2/1/2013: PagerDuty venture capital transaction
Next: 2/2/2013: Ellie venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs